-
Ruchira Papers Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast
- August 12, 2026
- Posted by: Ankit Jaiswal
- Category: News
No Comments
Ruchira Papers share price target 2027 is Rs 154 (+49%), 2028 is Rs 166 (+60%), and 2030 is Rs 194 (+87%). Diversified stock long term analyst forecast.
-
Asian Markets Today on 12 August 2026: KOSPI Surges 4.12 Percent to 6,607 as Robust Tech Earnings Drive MSCI Asia Pacific Higher
- August 12, 2026
- Posted by: Kunal Singla
- Category: News
Asian markets today on 12 August 2026 mostly higher: KOSPI +4.12% at 6,607, Nikkei +0.34% at 67,196, Jakarta +0.79%, Shanghai +0.21%. Hang Seng -0.98%, Straits Times -0.60%. Robust tech earnings boost MSCI Asia Pacific +0.6%.
-
KPI Green Energy Q1 FY27 Results: Revenue Rs 693 Cr, PAT Rs 94 Cr and Key Highlights
- August 12, 2026
- Posted by: Neeraj Pandey
- Category: News
KPI Green Energy Q1 FY27 results: Revenue Rs 693 Cr, PAT Rs 94 Cr. Key highlights, performance, FY27 outlook. Read full results analysis here.
-
Shakti Pumps (India) Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast
- August 12, 2026
- Posted by: Ankit Jaiswal
- Category: News
Shakti Pumps (India) share price target 2027 is Rs 555 (+0%), 2028 is Rs 620 (+11%), and 2030 is Rs 775 (+39%). Diversified stock long term analyst forecast.
-
EPL Q1 FY27 Results: Revenue Rs 1,387 Cr, PAT Rs 98 Cr and Key Highlights
- August 12, 2026
- Posted by: Neeraj Pandey
- Category: News
EPL Q1 FY27 results: Revenue Rs 1,387 Cr, PAT Rs 98 Cr. Key highlights, performance, FY27 outlook. Read full results analysis here.
-
Piccadily Agro Q1 FY27 Results: Revenue Rs 270 Cr, PAT Rs 21 Cr and Key Highlights
- August 12, 2026
- Posted by: Neeraj Pandey
- Category: News
Piccadily Agro Q1 FY27 results: Revenue Rs 270 Cr, PAT Rs 21 Cr. Key highlights, performance, FY27 outlook. Read full results analysis here.
-
Zydus Lifesciences Share Price in Focus After Sentynl Therapeutics Signs Alvelestat US Commercialisation and Global Manufacturing Rights Deal With Mereo BioPharma on 12 August 2026
- August 12, 2026
- Posted by: Kunal Singla
- Category: News
Zydus Lifesciences share price in focus as Sentynl Therapeutics subsidiary signs option and licence agreement with Mereo BioPharma for US rights to Alvelestat for AATD-LD. Potential first oral treatment for this rare genetic lung disease.
-
Pros and Cons of Investing in Chemplast Sanmar Share: PVC and Specialty Chem Analysis
- August 12, 2026
- Posted by: Ankit Jaiswal
- Category: News
Five pros including PVC and specialty chlorochemicals leadership and Sanmar Group backing, and four cons including PVC price cyclicality and feedstock dependence, of Chemplast Sanmar share.
-
Bata India Q1 FY27 Results: Revenue Rs 978 Cr, PAT Rs 63 Cr and Key Highlights
- August 12, 2026
- Posted by: Neeraj Pandey
- Category: News
Bata India Q1 FY27 results: Revenue Rs 978 Cr, PAT Rs 63 Cr. Key highlights, performance, FY27 outlook. Read full results analysis here.
-
Pramodini Medicare Initial Public Offering Day 1 Opens 12 August 2026: Healthcare Company Subscription Open on BSE SME
- August 12, 2026
- Posted by: Neeraj Pandey
- Category: News
Pramodini Medicare initial public offering Day 1 subscription opens 12 August 2026 and closes 14 August 2026. BSE SME healthcare IPO. Key details, risks, and how to apply for this offering.